After seven months of clinical investigation, Validcare, a research software and services company, announced March 22 that its team of principal investigators met with members of the U.S. Food and Drug Administration’s Cannabis Product Council (formerly known as the Cannabis Work Group) to share initial findings from the industry-sponsored, decentralized human safety study of hemp-derived CBD products. Preliminary findings showed no evidence of liver disease and no increase in the prevalence of elevated liver function tests in adults who ingest oral CBD products when compared to a population with a similar incidence of medical conditions.
Hemp Fiber Hit Processing Bottleneck in 2020
In the U.S., hemp fiber farmers’ production outpaced the country’s processing capacity in 2020, leaving some farmers without a clear path to market.
2020 U.S. hemp fiber production volume.
2020 U.S. hemp fiber processing capacity.
2020 Canadian hemp fiber processing capacity.
Source: New Frontier Data